Answers are grounded in this paper and cite their sources.
Platform report demonstrates scalable multi-omics analysis and automated provenance tracking across microbiome datasets, highlighting enhanced reproducibility in data science.
We present QIIME 2, an open-source microbiome data science platform accessible to users spanning the microbiome research ecosystem, from scientists and engineers to clinicians and policy makers. QIIME 2 provides new features that will drive the next generation of microbiome research. These include interactive spatial and temporal analysis and visualization tools, support for metabolomics and shotgun metagenomics analysis, and automated data provenance tracking to ensure reproducible, transparent microbiome data science.
No takes yet. Share an insight, caveat, or question.
Bolyen et al. (2018) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: